https:\/\/zoom.us\/j\/5731453473<\/a><\/p>\nThe link to claim credit for the session will be academiccme.com\/myaeval.<\/p>\n","protected":false},"excerpt":{"rendered":"
This program will be co-moderated by Joseph Campellone, MD, and James F. Howard Jr., MD Friday, April 15, 2022 12:30 p.m. to 1:30 p.m. Residents may attend by reporting to the conference center, room 121 or virtually via Zoom. Zoom Link: https:\/\/zoom.us\/j\/5731453473 The link to claim credit for the session will be academiccme.com\/myaeval.<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-rmineo","4":"post-15346","6":"format-standard","7":"category-uncategorized"},"yoast_head":"\n
Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds\" \/>\n<meta property=\"og:description\" content=\"This program will be co-moderated by Joseph Campellone, MD, and James F. Howard Jr., MD Friday, April 15, 2022 12:30 p.m. to 1:30 p.m. Residents may attend by reporting to the conference center, room 121 or virtually via Zoom. Zoom Link: https:\/\/zoom.us\/j\/5731453473 The link to claim credit for the session will be academiccme.com\/myaeval.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"Weekly Rounds\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-12T19:20:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-12T19:57:59+00:00\" \/>\n<meta name=\"author\" content=\"Cooper University Health Care\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cooper University Health Care\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/\",\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/\",\"name\":\"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website\"},\"datePublished\":\"2022-04-12T19:20:36+00:00\",\"dateModified\":\"2022-04-12T19:57:59+00:00\",\"author\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/dd2141265d302a4c02cc98d5bbd84397\"},\"breadcrumb\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website\",\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/\",\"name\":\"Weekly Rounds\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/dd2141265d302a4c02cc98d5bbd84397\",\"name\":\"Cooper University Health Care\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4a48f444c98accfabda360787966b9771492143d3a9694302d5680ea6bce1cb8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4a48f444c98accfabda360787966b9771492143d3a9694302d5680ea6bce1cb8?s=96&d=mm&r=g\",\"caption\":\"Cooper University Health Care\"},\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/author\/rmineo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds","og_description":"This program will be co-moderated by Joseph Campellone, MD, and James F. Howard Jr., MD Friday, April 15, 2022 12:30 p.m. to 1:30 p.m. Residents may attend by reporting to the conference center, room 121 or virtually via Zoom. Zoom Link: https:\/\/zoom.us\/j\/5731453473 The link to claim credit for the session will be academiccme.com\/myaeval.","og_url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/","og_site_name":"Weekly Rounds","article_published_time":"2022-04-12T19:20:36+00:00","article_modified_time":"2022-04-12T19:57:59+00:00","author":"Cooper University Health Care","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Cooper University Health Care"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/","url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/","name":"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies - Weekly Rounds","isPartOf":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website"},"datePublished":"2022-04-12T19:20:36+00:00","dateModified":"2022-04-12T19:57:59+00:00","author":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/dd2141265d302a4c02cc98d5bbd84397"},"breadcrumb":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2022\/04\/neuroscience-grand-rounds-advances-in-disease-management-of-generalized-myasthenia-gravis-by-reducing-levels-of-igg-autoantibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/"},{"@type":"ListItem","position":2,"name":"Neuroscience Grand Rounds: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies"}]},{"@type":"WebSite","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website","url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/","name":"Weekly Rounds","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/dd2141265d302a4c02cc98d5bbd84397","name":"Cooper University Health Care","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4a48f444c98accfabda360787966b9771492143d3a9694302d5680ea6bce1cb8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4a48f444c98accfabda360787966b9771492143d3a9694302d5680ea6bce1cb8?s=96&d=mm&r=g","caption":"Cooper University Health Care"},"url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/author\/rmineo\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/15346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/comments?post=15346"}],"version-history":[{"count":1,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/15346\/revisions"}],"predecessor-version":[{"id":15348,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/15346\/revisions\/15348"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/media?parent=15346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/categories?post=15346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/tags?post=15346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}